22157.jpg
COVID-19 Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances Analysis: A Round-up of Crucial Developments
October 27, 2020 05:23 ET | Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances - Comprehensive Bundle" report has been added to...
GOVX new logo.png
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
October 26, 2020 09:00 ET | GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
22157.jpg
Global Influenza Vaccines Markets Report 2020: Quadrivalent is the Dominant Type of Influenza Vaccine - Forecast to 2028
October 01, 2020 04:49 ET | Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccines Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global influenza vaccines market is...
22157.jpg
COVID-19 Vaccine Developments: 6 Daily Updates, 6 Weekly Summary Reports, 6 Monthly Synthesis Reports
September 15, 2020 05:38 ET | Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle" report has been added to...
22157.jpg
COVID-19 Vaccine Reporting Subscription: Development, Therapeutics Experiments and Diagnostics/Devices Advances
September 10, 2020 10:58 ET | Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/Devices Advances - Basic Bundle" report has been added to...
22157.jpg
US Influenza Vaccines Market Size and Analysis 2020: Clinical Trial Insights by Phase, Company and Country
September 04, 2020 06:34 ET | Research and Markets
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Forecast 2020 - 2027" report has been added to ResearchAndMarkets.com's offering. The United States...
22157.jpg
COVID-19 Mitigation Products Market Outlook 2020-2024 - Forecast to Reach $1.6 Trillion (Scenario A); $2.2 Trillion (Scenario B), with Insights Into 248 Sub-Markets
August 31, 2020 04:44 ET | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Mitigation Products: Market Research, to 2024" report has been added to ResearchAndMarkets.com's offering. On the backdrop of the global...
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
August 25, 2020 10:24 ET | Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
August 18, 2020 09:15 ET | Codex
San Diego, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical...
emergent logo.jpg
Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate
July 27, 2020 06:30 ET | Emergent BioSolutions
Emergent will provide contract development and manufacturing services beginning in 2020 to produce drug substance at large scale for commercial supplyAgreement is valued at approximately $174 million...